Transcriptomas evaluation of polymyxin B resistant Acinetobacter baumannii clinical isolates

• Grant number: 12/15458-0
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• Start date: October 01, 2012
• End date: September 30, 2014
• Field of knowledge: Biological Sciences - Microbiology - Applied Microbiology
• Principal Investigator: Ana Cristina Gales
• Grantee: Raquel Girardello
• Host Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil

Abstract

A. baumannii is a common pathogen associated to health care infections in Brazil, due to its capacity to survive in adverse conditions and develop resistance to broad spectrum antimicrobial agents. The high resistance rate combined to together with the absence of new antimicrobial options turned polymyxins the last line antimicrobial drugs to treat Gram negative MDR infections. The aim of this study is to analyze the transcriptomes of the polymyxin B susceptible and resistance A. baumannii clinical isolates. The strains will be submitted to the polymyxin B exposure and the susceptibility profile will be performed. The transcriptomes of the clinical isolates and their induced mutants will be determined and analyzed by comparision. The transcriptome results will be confirmed by Real Time PCR. The membrane potential will be measured before and after the polymyxin B exposure. Virulence experiments will be performed by in vivo model C. elegans.

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

GIRARDELLO, RAQUEL; VISCONDE, MARINA; CAYO, RODRIGO; BRESSAN QUEIROZ DE FIGUEIREDO, REGINA CELIA; DA SILVA MORI, MARCELO ALVES; LINCOPAN, NILTON; GALES, ANA CRISTINA. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, v. 87, n. 1, p. 37-44, JAN 2017. (10/12891-9, 12/15458-0, 12/15459-6)